App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa

Sponsor
Yeshiva University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05753410
Collaborator
Yale University (Other)
20
1
1
12
1.7

Study Details

Study Description

Brief Summary

We will evaluate the acceptability and feasibility of a 8-week long digital mindfulness-based intervention for anorexia nervosa and bulimia nervosa.

This study is a prospective single-arm trial during the intervention development phase. Following this phase, after the intervention has been further developed, a subsequent study (with a different clinicaltrials.gov identification #) will utilize a randomized control trial design.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindful Courage
N/A

Detailed Description

Procedures include completing: (1) pre-intervention screening assessment; (2) brief daily assessments for the first and last weeks of the study (4 times per day); (3) an initial baseline visit; (4) 8-week web-based intervention (3) a post-intervention assessment (8-weeks after baseline); and (4) a brief 8-week follow-up assessment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Feasibility and Acceptability of an App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindful Courage

Mindful Courage is a digital intervention including mindfulness and cognitive behavioral elements for individuals with anorexia nervosa or bulimia nervosa. Mindful Courage will consist of 8-weeks of self-guided modules which will be completed over the course of 8 weeks. Elements included in the intervention include psychoeducation, self-monitoring, regular eating, body image, values clarification, and mindful awareness and acceptance. Participants learn a range mindfulness skills and practice a range of mindfulness meditations. Participants will also receive phone coaching. Homework consists of meditation practices.

Behavioral: Mindful Courage
Self-guided online intervention

Outcome Measures

Primary Outcome Measures

  1. Feasibility [8-week treatment period]

    Module completion, ranging from 0 to 100%

  2. Acceptability dimensions [8-week treatment period]

    Single-items measuring ratings of acceptability dimensions, including usability, understandability, engage-ability, visual appeal, helpfulness, skill acquisition, and confidence implementing skills ratings. Scores for each item range from 1 to 5, , with higher scores indicating better acceptability.

Secondary Outcome Measures

  1. Change in Eating Disorder Symptoms [Baseline to post-treatment (8-weeks) and through 2-month follow-up]

    Eating Disorder Examination-Questionnaire (EDE-Q). Total scores are the average of each of the subscales, and range from 0 to 6. Higher scores indicate higher eating disorder symptoms.

  2. Change in Emotion Dysregulation [Baseline to post-treatment (8-weeks) and through 2-month follow-up]

    Difficulties in Emotion Regulation Short Form (DERS-SF). Total scores are the average of each of the subscales, and range from 1 to 5. Higher scores indicate more emotion dysregulation

  3. Change in Body Dissatisfaction [Baseline to post-treatment (8-weeks) and through 2-month follow-up]

    Body Shape Questionnaire (BSQ). Total scores are the total across the items, and range from 34 to 204. Higher scores indicate greater body dissatisfaction.

  4. Savoring Beliefs [Baseline to post-treatment(8-weeks) and through 2-month follow-up]

    Savoring Beliefs Inventory (SBI). Total scores are the total across the positively-anchored and negatively-anchored items, and could range from -72 to 72. Higher scores reflect stronger endorsement of savoring beliefs.

  5. Psychosocial Impairment [Baseline to post-treatment (8-weeks) and through 2-month follow-up]

    Clinical Impairment Assessment Questionnaire (CIA). Total scores are the total of the items, and range from 0 to 48. Higher scores indicate greater psychosocial impairment associated with an eating disorder.

  6. Change in Mindfulness [Baseline to post-treatment (8-weeks) and through 2-month follow-up]

    Cognitive and Affective Mindfulness Scale-Revised (CAMS-R). Total scores range from 0 to 40, with higher scores indicating greater mindfulness.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years of age or older

  • Can read and write in English

  • Meet diagnostic DSM 5 diagnostic criteria for anorexia nervosa, bulimia nervosa, or atypical anorexia nervosa/bulimia nervosa

  • Owns a smartphone

  • Willing and able to participate in an eight-week long research study

  • Have a private quiet space at home or headphones to complete modules

  • Completed one month or more of eating disorder treatment

  • Currently enrolled in eating disorder treatment

Exclusion Criteria:
  • Fail to meet above-listed inclusion criteria

  • Current alcohol or drug dependence

  • Current untreated psychotic or bipolar disorder

  • Current suicidal intent

  • Significant cognitive impairment that would impair the ability to use Mindful Courage effectively

  • BMI <15 or medically unstable

  • Currently receiving residential/inpatient treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Margaret Sala Bronx New York United States 10461-1915

Sponsors and Collaborators

  • Yeshiva University
  • Yale University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Margaret Sala, Assistant Professor, Yeshiva University
ClinicalTrials.gov Identifier:
NCT05753410
Other Study ID Numbers:
  • 20204635
First Posted:
Mar 3, 2023
Last Update Posted:
Mar 3, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Margaret Sala, Assistant Professor, Yeshiva University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2023